This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.

NCT01702376 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstetric Labour, Premature

Interventions

DRUG: Retosiban 100 mg
DRUG: Retosiban 800 mg
DRUG: Placebo
DRUG: Moxifloxacin 400 mg

Sponsor

GlaxoSmithKline